Physician profile
David Barnes
NPI 1265828420
$13,641.53
in general payments reported to CMS, 2019-2025
26 companies · $2,189 in 2025
The $2,189 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $7,331 · 2021: $1,864 · 2022: $725 · 2023: $546 · 2024: $986 · 2025: $2,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101 · Travel and Lodging: $1,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.69 |
| Travel and Lodging | $1,620.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $7,275.94 | 2020-2021 | |
| Medical Device Business Services, INC. | $1,473.74 | 2020-2025 | Velys |
| Globus Medical, INC. | $1,353.96 | 2021-2024 | Excelsiusgps Robotic Navigation System |
| Boston Scientific Corporation | $1,041.98 | 2022-2025 | General - Pain Management, Artisan, Coveredge 32 |
| Centinel Spine, LLC | $904.36 | 2021-2024 | Prodisc L, Prodisc C Vivo |
| Providence Medical Technology, INC. | $268.02 | 2023-2025 | |
| Medtronic, INC. | $262.01 | 2023-2025 | Space-D System 5.5/6.0 Voyager Instrument Set, Intellis Adaptivestim, Mazor X System |
| Aesculap Implant Systems, LLC | $149.51 | 2021 | |
| Si-Bone, INC. | $117.39 | 2021-2023 | |
| Cerapedics INC. | $116.40 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $106.86 | 2021-2025 | Velys |
| Paragon 28, INC. | $88.65 | 2020 | |
| Augmedics INC. | $66.85 | 2024 | Xvision |
| Relievant Medsystems, INC. | $57.90 | 2023 | Intracept |
| Nevro Corp. | $48.15 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $45.57 | 2020 | |
| Medacta USA, INC. | $44.74 | 2021 | |
| Xtant Medical INC | $41.36 | 2024 | |
| Innovation Technologies INC | $36.30 | 2025 | Irrisept |
| Ethicon US, LLC | $29.15 | 2022 | |
| Siemens Medical Solutions USA, INC. | $28.72 | 2023 | Magnetom Free.Max |
| Stryker Corporation | $21.17 | 2020 | |
| Pfizer INC. | $17.37 | 2025 | |
| Kci USA, INC. | $15.78 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $15.64 | 2025 | |
| Smith+Nephew, INC. | $14.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.